share_log

Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy A. Springer(36.7%),TAS Partners LLC(11.7%), etc.

Cartesian Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Timothy A. Springer(36.7%),TAS Partners LLC(11.7%)等

美股SEC公告 ·  2024/09/27 13:24
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息